Saasa N, Mkandawire E, Ndebe J, Mwenda M, Chimpukutu F, Mukubesa A
Pathogens. 2024; 13(6).
PMID: 38921784
PMC: 11206273.
DOI: 10.3390/pathogens13060486.
Munshili Njifon H, Kenmoe S, Ahmed S, Takuissu G, Ebogo-Belobo J, Kamga Njile D
J Infect Dis. 2023; 229(5):1470-1480.
PMID: 37962924
PMC: 11095554.
DOI: 10.1093/infdis/jiad500.
Maina M, Faneye A, Motayo B, Nseabasi-Maina N, Adeniji A
J Int Med Res. 2022; 50(9):3000605221121956.
PMID: 36138570
PMC: 9511342.
DOI: 10.1177/03000605221121956.
Mwangi P, Page N, Seheri M, Mphahlele M, Nadan S, Esona M
Microb Genom. 2022; 8(4).
PMID: 35446251
PMC: 9453071.
DOI: 10.1099/mgen.0.000809.
Omatola C, Ogunsakin R, Olaniran A
Viruses. 2021; 13(10).
PMID: 34696335
PMC: 8538439.
DOI: 10.3390/v13101905.
Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.
Vetter V, Gardner R, Debrus S, Benninghoff B, Pereira P
Hum Vaccin Immunother. 2021; 18(1):1870395.
PMID: 33605839
PMC: 8920198.
DOI: 10.1080/21645515.2020.1870395.
Multiple Introductions and Predominance of Rotavirus Group A Genotype G3P[8] in Kilifi, Coastal Kenya, 4 Years after Nationwide Vaccine Introduction.
Mwanga M, Verani J, Omore R, Tate J, Parashar U, Murunga N
Pathogens. 2020; 9(12).
PMID: 33255256
PMC: 7761311.
DOI: 10.3390/pathogens9120981.
Norovirus and rotavirus in children hospitalised with diarrhoea after rotavirus vaccine introduction in Burkina Faso.
Ronnelid Y, Bonkoungou I, Ouedraogo N, Barro N, Svensson L, Nordgren J
Epidemiol Infect. 2020; 148:e245.
PMID: 32998792
PMC: 7592103.
DOI: 10.1017/S0950268820002320.
Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.
Folorunso O, Sebolai O
Vaccines (Basel). 2020; 8(3).
PMID: 32604982
PMC: 7565912.
DOI: 10.3390/vaccines8030341.